Telescoping bifurcated stent

Abstract
A bifurcated stent that uses telescoping rings to support or form the side branch lumen. This design allows the bifurcation branch to extend easily, to a useful distance, and to be deployed along oblique angles. Best of all, this design avoids the need to deploy a bent stent.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

Not Applicable


STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH

Not Applicable


BACKGROUND OF THE INVENTION

1. Field of the Invention


In some embodiments this invention relates to implantable medical devices, their manufacture, and methods of use. Some embodiments are directed to delivery systems, such as catheter systems of all types, which are utilized in the delivery of such devices.


2. Description of the Related Art


A stent is a medical device introduced to a body lumen and is well known in the art. Typically, a stent is implanted in a blood vessel at the site of a stenosis or aneurysm endoluminally, i.e. by so-called “minimally invasive techniques” in which the stent in a radially reduced configuration, optionally restrained in a radially compressed configuration by a sheath and/or catheter, is delivered by a stent delivery system or “introducer” to the site where it is required. The introducer may enter the body from an access location outside the body, such as through the patient's skin, or by a “cut down” technique in which the entry blood vessel is exposed by minor surgical means.


Stents, grafts, stent-grafts, vena cava filters, expandable frameworks, and similar implantable medical devices, collectively referred to hereinafter as stents, are radially expandable endoprostheses which are typically intravascular implants capable of being implanted transluminally and enlarged radially after being introduced percutaneously. Stents may be implanted in a variety of body lumens or vessels such as within the vascular system, urinary tracts, bile ducts, fallopian tubes, coronary vessels, secondary vessels, etc. Stents may be used to reinforce body vessels and to prevent restenosis following angioplasty in the vascular system. They may be self-expanding, expanded by an internal radial force, such as when mounted on a balloon, or a combination of self-expanding and balloon expandable (hybrid expandable).


Stents may be created by methods including cutting or etching a design from a tubular stock, from a flat sheet which is cut or etched and which is subsequently rolled or from one or more interwoven wires or braids.


Within the vasculature, it is not uncommon for stenoses to form at a vessel bifurcation. A bifurcation is an area of the vasculature or other portion of the body where a first (or parent) vessel is bifurcated into two or more branch vessels. Where a stenotic lesion or lesions form at such a bifurcation, the lesion(s) can affect only one of the vessels (i.e., either of the branch vessels or the parent vessel) two of the vessels, or all three vessels. Many prior art stents however are not wholly satisfactory for use where the site of desired application of the stent is juxtaposed or extends across a bifurcation in an artery or vein such, for example, as the bifurcation in the mammalian aortic artery into the common iliac arteries.


The art referred to and/or described above is not intended to constitute an admission that any patent, publication or other information referred to herein is “prior art” with respect to this invention. In addition, this section should not be construed to mean that a search has been made or that no other pertinent information as defined in 37 C.F.R. §1.56(a) exists.


All US patents and applications and all other published documents mentioned anywhere in this application are incorporated herein by reference in their entirety.


Without limiting the scope of the invention a brief summary of some of the claimed embodiments of the invention is set forth below. Additional details of the summarized embodiments of the invention and/or additional embodiments of the invention may be found in the Detailed Description of the Invention below.


A brief abstract of the technical disclosure in the specification is provided as well only for the purposes of complying with 37 C.F.R. 1.72. The abstract is not intended to be used for interpreting the scope of the claims.


All U.S. patents and applications and all other published documents mentioned anywhere in this application are incorporated herein by reference in their entirety.


BRIEF SUMMARY OF THE INVENTION

This invention contemplates a number of embodiments where any one, any combination of some, or all of the embodiments can be incorporated into a stent and/or a stent delivery system and/or a method of use. In the context of these embodiments, the term telescoping means to extend away from a stent wall in a direction different from that of the longitudinal axis of a stent. Telescoping includes but is not limited each or any combination of: extending along a linear, varied, or curved path; extending at an oblique angle from the longitudinal axis of the stent; as well as extending along a path parallel to the longitudinal axis of the stent.


At least one embodiment of the invention is directed to a bifurcated stent being expandable from an unexpanded state to an expanded state, with a diameter smaller in the unexpanded state having a substantially tubular primary body defining a primary circumferential plane, a primary outer surface, a primary lumen and having a primary longitudinal axis extending therethrough; and a side branch assembly engaged to the primary body having at least one ring member, which is positioned substantially within the primary circumferential plane in the unexpanded state and defining a secondary circumferential plane, a secondary lumen, and having a secondary longitudinal axis extending therethrough, in the expanded state. The secondary lumen is in fluid communication with the primary lumen and forms an oblique angle with the primary longitudinal axis.


At least one embodiment of the invention is directed to a stent containing a bifurcation branch formed out of at least one ring connected to the stent. When deployed, this stent bridges vessel bifurcations by telescoping and aligning at least one ring into the vessel bifurcation. This bifurcation branch is an additional stent channel forking away from the first channel defined by the main body of the stent. The bifurcation branch is in fluid communication with the first channel and is formed by one or more rings in fluid communication with the main stent body. The rings are connected to the stent and (if there is more than one ring) to each other by connectors. In some embodiments, a telescoping ring bifurcation branch is configured to extend farther than a petal shaped stent bifurcation branch.


At least one embodiment of the invention is directed to a stent containing a bifurcation branch of two or more interconnected rings in fluid communication with the main stent body in which at least one ring is in an unextended state when the branch is not telescoped. When the branch is telescoped, the unextended ring(s) assume an extended state.


At least one embodiment of the invention is directed to a bifurcation branch of one or more rings in fluid communication with the main stent body in which the ring-ring or ring-stent connectors have a first length when the branch is untelescoped and a second length when the stent is telescoped. These different connector lengths allow for the rings to have a low profile when untelescoped and to allow for the rings to form a bifurcation branch of a large length when telescoped. This embodiment encompasses but is not limited to any stent connector known to people of ordinary skill in the art which has a longer length when expanded than when unexpanded.


At least one embodiment of the invention is directed to a bifurcation branch of one or more rings in fluid communication with the main stent body in which the ring-ring or ring-stent connectors have a bent structure when untelescoped that substantially straightens when telescoped.


At least one embodiment of the invention is directed to a bifurcation branch of one or more rings in fluid communication with the main stent body in which a ring-ring or ring-stent connectors is a flexible sinusoidal connector


At least one embodiment of the invention is directed to a bifurcation branch of one or more rings in fluid communication with the main stent body in which a ring-ring or ring-stent connector is a pivot mechanism whose rotational motion changes the distance spanned by the connector.


At least one embodiment of the invention is directed to a bifurcation branch of one or more rings in fluid communication with the main stent body in which a ring-ring or ring-stent connector is a spring whose extension changes the distance spanned by the connector.


At least one embodiment of the invention is directed to a stent containing a bifurcation branch of two or more interconnected rings where when the branch is untelescoped, the rings are in an unexpanded state and are positioned concentrically adjacent to each other within or adjacent to the circumferential plane of the ring directly connected to the main stent body.


At least one embodiment of the invention is directed to a stent containing a bifurcation branch of at least one ring which has the configuration of an at least a partially self overlapping loop when unextended and contains a self extending mechanism. This mechanism expands the rings by removing the loop overlap when forming a stent bifurcation branch.


At least one embodiment of the invention is directed to a stent with a ring bifurcation branch containing a current detachment mechanism. In this embodiment, a locking mechanism restrains the telescoping and/or the ring extension from expanding until an electrical current is applied. Once applied, the current causes the mechanism to detach from the rings allowing the rings to expand and/or to telescope and form a bifurcation branch.


At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which a ring may extend until either a pre-defined circumference is reached or until the extension is blocked by an anatomical feature.


At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which a ring contains a ratchet configuration which allows it to either increase or decrease its circumference by moving a locking mechanism along a ring's perimeter in one direction. Because the ratchet configuration prevents the locking mechanism from moving in the reverse direction, it prevents any change in circumference size in the opposite direction.


At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which a ring or connector is made out of metal(s), polymer(s), and/or combinations thereof.


At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which the ring bifurcation is fed into the side body vessel by a support wire.


At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which when the final shape of the bifurcation branch is assumed, the branch is locked into place with a single or multiple tongue and grove latch mechanism.


At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which the branch is formed before the stent is expanded.


At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which the branch is formed after the stent is expanded.


At least one embodiment of the invention is directed to a stent with a ring bifurcation branch in which the branch is formed at substantially the same time that the stent is expanded.


This invention also encompasses embodiments where at least one ring member has an unexpanded circumference in the unexpanded state and an expanded circumference in the expanded state, wherein the expanded circumference is greater than the unexpanded circumference, where adjacent ring members are engaged one to the other by at least one connector, and where at least one connector has a first end, a second end and a length therebetween, each end being flexibly engaged to one of the rings.


This invention also encompasses embodiments where in the unexpanded state the plurality of rings are concentrically arranged relative to one another, where in the unexpanded state the ring members are positioned laterally adjacent to one another, where at least one of the expanded state and the unexpanded state at least two ring members have differing circumferences, and where the secondary lumen comprises a length and a diameter, the diameter tapering along at least a portion of the length.


This invention also encompasses embodiments where at least one connector comprises a polymeric sheath, where the polymeric sheath is at least partially constructed out of PTFE, where at least one ring member comprises a ratchet mechanism, in the expanded state the ratchet mechanism preventing the expanded circumference from reverting to a circumference smaller than the expanded circumference, where at least one ring member is constructed and arrange to self expand from the unexpanded circumference to the expanded circumference, where at least one ring member is engaged to the primary body by at least one engagement region, the at least one engagement region having an engaged state and a released state, in the engaged state the at least one ring member being retained in the unexpanded state and in the released state the at least one ring member being released to expand to the expanded state.


At least one embodiment of the invention is directed to a stent delivery system having an unexpanded state and an expanded state, a catheter having an elongated shaft connected to a distal end; and a stent, the stent having a generally tubular main body, the main body having a diameter, the main body defining an interior, a side branch opening, and a side branch assembly adjacent to the side branch opening, the side branch assembly comprising at least one ring, there being a distance between the main body and the at least one ring, in the unexpanded state the diameter of the main body being less than the diameter of the main body in the expanded state, in the unexpanded state the distance being less than the distance in the expanded state; wherein the in the unexpanded state, the stent is disposed the distal end of the catheter.





BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS

The invention is best understood from the following detailed description when read in connection with accompanying drawings, in which:



FIG. 1 is an image of an unexpanded stent containing an unextended ring type telescoping bifurcation branch.



FIG. 2 is an image of an expanded stent containing an extended ring type telescoping bifurcation branch.



FIG. 3 is a close up view of an unextended ring type telescoping bifurcation branch.



FIG. 4 is a close up view of an extended ring type telescoping bifurcation branch.



FIG. 5 is an image of a single unextended telescoping ring.



FIG. 6 is an image of a single extended telescoping ring.



FIG. 7 is an image of an expanded stent containing an extended ring type telescoping bifurcation branch with a PTFE covering.



FIG. 8 is an image of an unexpanded stent containing an ratcheting unextended ring type telescoping bifurcation branch.



FIG. 9 is an image of an expanded stent containing an extended ratcheting ring type telescoping bifurcation branch.



FIG. 10 is an image of a single unextended ratcheting telescoping ring.



FIG. 11 is an image of a single extended ratcheting telescoping ring.



FIG. 12 is an image of a single unextended telescoping ring with a single tongue and groove locking mechanism.



FIG. 13 is an image of a single extended telescoping ring with a single tongue and groove locking mechanism.



FIG. 14 is an image of a single unextended telescoping ring with a multiple tongue and groove locking mechanism.



FIG. 15 is an image of a single extended telescoping ring with a multiple tongue and groove locking mechanism.



FIG. 16 is an image of the stent with added unengaged support structure.



FIG. 17 is an image of the stent with added engaged support structure.



FIG. 18 is an image of a stent delivery system with the expanded stent upon a catheter.



FIG. 19 is a close up view of an unextended ring type telescoping bifurcation branch in which the rings have a cloverleaf shape.



FIG. 20 is an image of the two ends of a single unextended telescoping ring with a single tongue and groove locking mechanism in which a portion of the mechanism has a thrombic material on its surface to glue the ring ends together.



FIG. 21 is an image of the end of the two ends of a single unextended telescoping ring with a “plus” shaped single tongue and groove locking mechanism.



FIG. 22 is an image of the end of the two ends of a single unextended telescoping ring with a conical shaped single tongue and groove locking mechanism.



FIG. 23 is an image of a single unextended telescoping ring with wire stops.





DETAILED DESCRIPTION OF THE INVENTION

The invention will next be illustrated with reference to the figures wherein the same numbers indicate similar elements in all figures. Such figures are intended to be illustrative rather than limiting and are included herewith to facilitate the explanation of the apparatus of the present invention.


For the purposes of this disclosure, like reference numerals in the figures shall refer to like features unless otherwise indicated.


Depicted in the figures are various aspects of the invention. Elements depicted in one figure may be combined with, or substituted for, elements depicted in another figure as desired.


Referring now to FIG. 1 there is shown an embodiment of the invention featuring an undeployed substantially tubular stent 10 in an unexpanded state placed on a catheter shaft 20 positioned within a body vessel, the body vessel having a first vessel lumen 25 and a second vessel lumen 30 which forms bifurcation from the first vessel lumen 25. The stent 10 deployed within the first vessel lumen 25 and is oriented along a primary longitudinal axis 1 which is forms an angle oblique to the secondary longitudinal axis 2 running along the length of the second vessel lumen 30. Positioned adjacent to the second vessel lumen 30 is a ring type side branch assembly 40 engaged to the primary stent body 15 by at least one connector 42 at an engagement region 93. The surface of the primary stent body defines a primary circumferential plane 95. In the unexpanded state, the side branch assembly 40 is positioned substantially along the primary circumferential plane 95. For the purposes of this application, the term “oblique” refers to an angle of greater than zero degrees, such as an angle of between about 1 and about 180 degrees. An oblique angle explicitly includes angles of about 90 degrees.


Side branch assembly 40 in FIG. 1 features a number of unextended rings or ring members 41 connected by inter-ring connectors 43. Although this drawing shows five interconnected concentric ring members 41, this invention is not limited to this number or configurations and encompasses any similar device with one or more ring members 41. In one possible embodiment, the unextended ring members 41 can have dissimilar circumferences and/or can fit into each other in a concentric “target” like configuration. This invention is not limited to a concentric arrangement of the ring members and encompasses any and all possible configurations known to people of ordinary skill in the art including stacked ring members and overlapping “olympic” ring arrangements. This invention also contemplates ring members that have the same or different circumferences when in the unextended state.


Although FIG. 1 illustrates the rings as having a generally oval or circular shape, this invention encompasses possible embodiments in which at least one ring of the side branch assembly has a non-oval or non-circular shape. Some other possible shapes for the rings include but are not limited to ellipse, cloverleaf (as illustrated in FIG. 19), and angular. In addition any given ring need not have a uniform or symmetrical shape and can have an irregular region. Rings of different shapes or sizes can be combined to form the side branch assembly.


This invention encompasses a number of mechanisms for extending the ring members 41. One mechanism involves constructing the ring members to be biased towards naturally extending and then blocking this extension with a releasable restraint. One mechanism for releasing the restraint is by locating the restraint at the engagement region 93 and connecting it to a current detachment mechanism which will release the restraint when an electrical current is received. Similarly the side branch assembly 40 can also be constructed biased to telescope naturally and be held back by a releasable restraint.


One method of releasing a biased stent 10 and/or side branch assembly 40 is to remove a restraining sheath from the stent when ready for deployment. Another method is to use a current detachment mechanism that will release a restraint and allow the ring members 41 to extend upon the receipt of an electrical current which degrades the integrity of a portion of the restraint. Current detachment mechanisms which are suitable for use in the present application may be similar to such mechanism that are known to be used in the deployment of GDC coils. Examples of such mechanisms are shown and described in U.S. Pat. Nos. 5,578,074, 5,669,905, 5,984,929, and 6,579,308; the entire contents of each being incorporated herein by reference.


In some embodiment specially shaped balloons or the use of two or more balloons can be used to extend ring members or to telescope the side branch assembly 40.


Referring now to FIG. 2 there is shown an embodiment of the invention in which the stent 10 is in the expanded state and the ring type side branch assembly 40 is telescoped and is completely deployed. In the deployed state the primary stent body 15 defines a primary lumen 91, has a diameter 4 which is greater than the diameter the stent 10 had in the unexpanded state, and defines a primary circumferential plane, a primary outer surface, and a primary lumen extending about and along the primary longitudinal axis 1. The deployed side branch assembly 40 has at least one telescoped ring member 41 extended into the second vessel lumen 30, and forms a second stent lumen 92 having a second circumferential plane 96 in fluid communication with the primary lumen 91 of the primary stent body 15. This second stent lumen 92 extends about and along a secondary longitudinal axis 2 at an oblique angle to the primary longitudinal axis 1.


This deployment can be accomplished by one or multiple balloons, self expansion, or by any other commonly known mechanism. The side branch assembly 40 can be telescoped before, after, or at substantially the same time that the ring members themselves are extended, and telescoping can occur before, after, or at substantially the same time as the expansion of the primary stent body 10. The ring bifurcation branch can also be telescoped by being fed into the side branch vessel 30 by guide wire 73 (not shown). Once in place, the separate guide wire 73 could have a separate locking mechanism to keep the rings in place. In this illustration all but one of the ring members 41 are extended to a larger circumference than they possessed when untelescoped. As mentioned before, all the ring members 41 need not be of differing circumferences or sizes before telescoping and this invention encompasses devices where any of the ring members 41 are designed to keep constant, increase, or decrease their circumference when telescoped. The side branch assembly 40 projects into the second vessel lumen 30 along a second longitudinal axis 2 which forms an angle with the primary longitudinal axis 1 and can be bent, curved, straight, or posses any number of configurations. The design of the side branch assembly 40 allows for the design of longer side branches branch than can be easily designed with petal type stent configurations.


In this illustration, the ring-ring connectors 43 are longer than they were when the bifurcation branch was untelescoped. This invention contemplates embodiments in which the ring-ring 43 and the ring-stent 42 connectors can also have particular characteristics to facilitate telescoping of the side branch assembly 40. These characteristics include: increasing connector lengths by using one or any combination of commonly known stent connector structures including S shaped connectors, bent connectors, flexible sinusoidal connectors, spring shaped connectors; bending and stretching connectors by constructing them out of flexible or expandable materials, spring shaped connectors, straightening curved connectors; and facilitating connector movement by including pivot mechanisms or engaging the connectors to the ring members or primary stent body by rotating loops or rings. Connector rotation can also facilitate increasing the ring-ring distance.


Referring now to FIGS. 3 and 4 there are shown close up images of the ring type telescoping side branch assembly 40 made up of ring members 41 attached to the primary stent body 15 by connectors 42. The ring members 41 are also connected to each other by at least one inter-ring connector 43. FIG. 3 features an example of untelescoped ring members and FIG. 4 telescoped ring members.



FIG. 3 includes an untelescoped ring branch assembly 40 in which the unextended ring members 41 are positioned concentrically adjacent to each and within the primary circumferential plane 95. This is only one possible configuration and the ring members 41 can be of uniform size and or be positioned in a non-concentric configurations including laterally adjacent positioning. When the stent 10 is deployed in a body vessel, each ring member can have its circumference extend, contract, or remain constant as the vessel dimensions require. The ring members 41 can be designed to alter their circumference to either a pre-defined circumference or until they are blocked by the vessel walls. The length and shape of connectors 43 or 42 is one way of affecting how far the side branch assembly 40 can extend into the secondary vessel lumen 92. This invention also contemplates secondary lumens 92 having at least partially irregular circumferences and can be tapered (where the circumferences of a series of adjacent ring members 41 gradually and generally change in size).



FIG. 5 illustrates an embodiment of an extendable ring member 41 with an overlapping loop configuration. In this embodiment, the ring member 41 has a first ring end 60 and the second ring end 65 adjacent to each other. While unextended, the ring member 41 has an overlap region 45 which reduces the circumference. As the ring member extends, the length of the overlapping region 45 decreases, increasing the circumference. An optional cover 75 can be placed over the overlap region but is not a required component of this embodiment.



FIG. 6 illustrates an embodiment of an extended ring 41 where some of or all of the overlapped portion of FIG. 5 are no longer overlapping thus increasing the ring's circumference. The extent of the circumferential increase caused by the rings expansion can be controlled by the use of wire stops or stopping welds. FIG. 23 illustrates an unexpanded ring in which a wire stop 36 and a stopping weld 37 is added to the ring. As the ring expands and the overlap region 45 decreases, the wire stop 36 moves closer to the opposite ring end (60 or 65). At some point the wire stop 36 becomes caught and stops further ring expansion. In one possible embodiment, the wire stop 36 is stopped when it becomes caught on a stopping weld 37 which can be in the form of a cavity, a hook or other catching region of the cover 75. Although this illustration shows two wire stops on the ends (60, 65) of the rings one or more wire stops can be installed on any region of the ring. In addition, the wire stops can function with or without stopping welds 37 or a cover 75.



FIG. 7 illustrates en embodiment of the invention in which the rings 41 of the ring bifurcation branch 40 are engaged to a polymeric sheath 70. This sheath can be constructed out of a number of materials including PTFE (poly(tetrafluoroethylene)) and can be constructed with a variety of flexibility, structural strength, rigidity, and porosity characteristics. The sheath can be positioned within or without the ring members' circumference or the rig members can be an integrated component embedded within at least a portion of the sheath material. This embodiment also contemplates a plurality of sheath layers made up of different materials, having different characteristics, or different positions. The sheath can be designed to fold open as the side branch 40 telescopes during deployment.


There are a number of possible mechanisms that can be used to lock an extended ring member into its final configuration and to assure that the ring member only extends (or contracts) in the desired direction and does not assume an undesired circumference. One of these mechanisms, illustrated in FIGS. 8, 9, 10 and 11 is a ratcheting ring. The ratcheting ring utilizes a locking mechanism used today to fix the circumference of rings locking wires together or sealing waste disposal bags, is commonly referred to as “cable ties”, “tie wraps”, or “zip ties” and is well known to people of ordinary skill in the art.


A side branch assembly 40 with this locking mechanism is illustrated in FIGS. 8 and 9. These figures show ring members 41 with ratchet teeth 50 disposed about at least a portion of the ring member's perimeter and a locking mechanism 51. When extending forces such as balloon pressure or self expansion cause the circumference of the ring member to change, the ratchet teeth 50 are capable of traversing the locking mechanism 51 in one direction but not in another fixing the resulting change in circumference. This mechanism can prevent an increase or a decrease in the size of the ring member 41 circumference. FIG. 8 illustrates unextended ratchet rings attached to an unexpanded stent body 15 and FIG. 9 illustrates extended ratchet rings telescoped into a second vessel body 30.



FIG. 10 illustrates a close up view of a ratchet ring 41. In it a ring member 41 has disposed about its circumference at least one ratchet tooth 50. Ratchet teeth can be triangular, or angled in such a way that locking mechanism 51 can easily rotate about the perimeter in one direction but is blocked from moving in the opposite direction by the tooth/teeth 50. As a result, the ring member 41 can be adjusted to assume a desired circumference and it will not revert back to it original circumference. FIG. 11 illustrates a ratchet ring after it has extended to a larger circumference.


Now referring to FIGS. 12 and 13, there is shown an expandable ring member 41 with a single tongue groove locking mechanism. FIG. 12 illustrates the ring member 41 in an unextended state wherein there is an overlap region 45 reducing the ring member's circumference. When this ring member 41 extends as shown in FIG. 13, the locking tongue 22 located on the first end 60 engages the groove 68 located on the ring member's second end 61. In the extended state, by reducing or eliminating the overlap region 45 the ring member's circumference increases. The locking mechanisms 22 and 68, prevent the ring from contracting once the extended circumference has been assumed.


There are a number of additional possible embodiments of the expandable ring member 41 with a single tongue groove locking mechanism. In one possible embodiment (as illustrated in FIG. 20), at least a portion of the locking mechanism has an adhesive or thrombogenic material 71 on its surface capable of at least partially binding the interlocked ends 60, 61 of the ring together. Although FIG. 20 illustrates the thrombogenic materials on specific regions of both ring ends, this embodiment encompasses thrombogenic materials on any region of either or both ring ends. In a second possible embodiment (as illustrated in FIG. 21), the locking mechanism 22 comprises a pin with a plus shaped extension 76 which fits into and engages a grove 68 with a plus shaped socket 77. In a third possible embodiment (as illustrated in FIG. 22), the locking mechanism 22 comprises a pin with a conical shaped extension 52 which fits into and engages a grove 68 with a cone shaped socket 53.


Now referring to FIGS. 14 and 15, there is shown an expandable ring with a multiple tongue groove locking mechanism. FIG. 14 illustrates the ring 41 in an unextended state wherein there is an overlap region 45 reducing the ring's circumference. When this ring extends as shown in FIG. 15, the locking tongue 22 located on the first end 60 engages the grooves 88. These groves allow for a number of possible extended states with a reduced or eliminated overlap region 45. The locking mechanisms 22 and 88 prevent the ring from contracting once the desired extended circumference has been assumed.


Referring now to FIGS. 16 and 17 are an embodiment of the stent in which there is added at least one structural support 34 with a support locking mechanism 33. The support locking mechanism 33 can be a hook located at the end of the structural support 34 or can be located at any position along the length of the structural support 34. The structural support 34 can be a wire or any flexible or curved material. In FIG. 16 the ring side branch assembly 40 has not yet telescoped so the structural support 55 has not yet engaged with the locking position 35 on the stent main body 15. In FIG. 17 at least one ring member 41 has been telescoped and the locking mechanism 33 has engaged the locking position 35. This structural support 34 can be used to both telescope the ring members 41 by pushing them out into the second vessel lumen 30 or they can be used to provide additional support connecting the side branch assembly 40 to the stent main body 10. In addition the support structure can replace the stent-ring or ring-ring connectors.


Referring now to FIG. 18 there is shown a longitudinal cross-sectional view of an example of a stent delivery system 78 capable of delivering a bifurcated stent 10 with a side branch assembly having at least one ring member 41 and at least one ring-ring and/or ring-stent connector 43 to form a second fluid lumen 30. The stent delivery system 78 includes a stent 10 disposed around the distal end of a catheter shaft 20. The distal end of the catheter shaft 20 is inserted through the first vessel lumen 25 of the main stent body 20. In this illustration the stent delivery system 78 is representative of a simple over-the-wire (OTW) or single-operator-exchange (SOE) angioplasty balloon catheter according to the invention. Such balloon catheters are discussed, for example, in commonly assigned U.S. Pat. Nos. 6,113,579, 6,517,515 and 6,514,228, each of which is incorporated by reference herein in its entirety. In this embodiment, the system also features a conventional OTW-type manifold assembly 72 connected to proximal end of catheter shaft assembly 20. The catheter shaft assembly 20 includes an outer tube 74 coaxially disposed about inner tube 73 which defines a guide wire lumen 77 and a distal end about which is disposed balloon 79. During deployment, the balloon 79 is inflated, thus expanding the stent at the lesion site. This is only an illustration of such a catheter assembly and is not intended to limit the scope of the present invention. This invention also encompasses stent delivery systems which do not contain a balloon expanding attributes such as self expanding stents or fixed wire systems. Numerous structures are known to those of skill in the art, any of which may be employed herein.


In some embodiments the stent, its delivery system, or other portion of an assembly may include one or more areas, bands, coatings, members, etc. that is (are) detectable by imaging modalities such as X-Ray, MRI, ultrasound, etc. In some embodiments at least a portion of the stent and/or adjacent assembly is at least partially radiopaque. In some embodiments the delivery system of the side deployment mechanism includes balloon inflation, self expansion, and guide wire pushing or pulling.


In some embodiments at least a portion of the stent is configured to include one or more mechanisms for the delivery of a therapeutic agent. Often the agent will be in the form of a coating or other layer (or layers) of material placed on a surface region of the stent, which is adapted to be released at the site of the stent's implantation or areas adjacent thereto.


A therapeutic agent may be a drug or other pharmaceutical product such as non-genetic agents, genetic agents, cellular material, etc. Some examples of suitable non-genetic therapeutic agents include but are not limited to: anti-thrombogenic agents such as heparin, heparin derivatives, vascular cell growth promoters, growth factor inhibitors, Paclitaxel, etc. Where an agent includes a genetic therapeutic agent, such a genetic agent may include but is not limited to: DNA, RNA and their respective derivatives and/or components; hedgehog proteins, etc. Where a therapeutic agent includes cellular material, the cellular material may include but is not limited to: cells of human origin and/or non-human origin as well as their respective components and/or derivatives thereof. Where the therapeutic agent includes a polymer agent, the polymer agent may be a polystyrene-polyisobutylene-polystyrene triblock copolymer (SIBS), polyethylene oxide, silicone rubber and/or any other suitable substrate.


This completes the description of the preferred and alternate embodiments of the invention. The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. The various elements shown in the individual figures and described above may be combined, substituted, or modified for combination as desired. All these alternatives and variations are intended to be included within the scope of the claims where the term “comprising” means “including, but not limited to”.


Further, the particular features presented in the dependent claims can be combined with each other in other manners within the scope of the invention such that the invention should be recognized as also specifically directed to other embodiments having any other possible combination of the features of the dependent claims. For instance, for purposes of claim publication, any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims). In jurisdictions where multiple dependent claim formats are restricted, the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claims below.

Claims
  • 1. A bifurcated stent being expandable from an unexpanded state to an expanded state, wherein in the unexpanded state the stent has a diameter less than that of the diameter in the expanded state, the bifurcated stent comprising: a substantially tubular primary body defining a primary circumferential plane, a primary outer surface, a primary lumen and having a primary longitudinal axis extending therethrough;a side branch assembly engaged to the primary body, the side branch assembly comprising a plurality of ring members, adjacent ring members being engaged one to the other by at least one connector, in the unexpanded state the plurality of ring members being positioned substantially within the primary circumferential plane, in the expanded state the plurality of ring members being positioned external to the primary circumferential plane and defining a secondary lumen, and having a secondary longitudinal axis extending therethrough, the secondary lumen being in fluid communication with the primary lumen, the secondary longitudinal axis forming an angle with the primary longitudinal axis, wherein the plurality of ring members are generally circular, andwherein the ring members have an unexpanded circumference in the unexpanded state and at least two of the plurality of ring members have substantially the same unexpanded circumference.
  • 2. The stent of claim 1 wherein the ring members have an expanded circumference in the expanded state, wherein the expanded circumference is greater than the unexpanded circumference.
  • 3. The stent of claim 2 wherein the ring members are constructed and arranged to self expand from the unexpanded circumference to the expanded circumference.
  • 4. The stent of claim 2 wherein the ring members are engaged to the primary body by at least one engagement region, the at least one engagement region having an engaged state and a released state, in the engaged state the at least one ring member being retained in the unexpanded state and in the released state the at least one ring member being released to expand to the expanded state.
  • 5. The stent of claim 1 wherein the at least one connector has a first end, a second end and a length therebetween, each end being flexibly engaged to one of the rings.
  • 6. The stent of claim 1 wherein the at least one of the expanded state and the unexpanded state of at least two ring members have differing circumferences.
  • 7. The stent of claim 1 wherein the secondary lumen comprises a length and a diameter, the diameter tapering along at least a portion of the length.
  • 8. A bifurcated stent being expandable from an unexpanded state to an expanded state, wherein in the unexpanded state the stent has a diameter less than that of the diameter in the expanded state, the bifurcated stent comprising: a substantially tubular primary body defining a primary circumferential plane, a primary outer surface, a primary lumen and having a primary longitudinal axis extending therethrough;a side branch assembly engaged to the primary body, the side branch assembly comprising a plurality of ring members, adjacent ring members being engaged one to the other by at least one connector, in the unexpanded state the plurality of ring members being positioned substantially within the primary circumferential plane, in the expanded state the plurality of ring members being positioned external to the primary circumferential plane and defining a secondary lumen, and having a secondary longitudinal axis extending therethrough, the secondary lumen being in fluid communication with the primary lumen, the secondary longitudinal axis forming an angle with the primary longitudinal axis, wherein the ring members have an unexpanded circumference in the unexpanded state and at least two of the plurality of ring members have substantially the same unexpanded circumference.
  • 9. The stent of claim 8, wherein the connectors are substantially straight in both the unexpanded state and the expanded state.
  • 10. The stent of claim 8, wherein the at least one of the expanded state and the unexpanded state of at least two ring members have differing circumferences.
  • 11. The stent of claim 8, wherein in the unexpanded state the plurality of ring members are concentrically arranged relative to one another.
US Referenced Citations (317)
Number Name Date Kind
1596754 Moschelle Aug 1926 A
1861769 Wappler Jun 1932 A
2845959 Sidebotham Aug 1958 A
3872893 Roberts Mar 1975 A
4309994 Grunwald Jan 1982 A
4410476 Redding et al. Oct 1983 A
4413989 Schjeldahl et al. Nov 1983 A
4421810 Rasmussen Dec 1983 A
4454887 Kruger Jun 1984 A
4552554 Gould et al. Nov 1985 A
4681570 Dalton Jul 1987 A
4689174 Lupke Aug 1987 A
4730616 Frisbie et al. Mar 1988 A
4769005 Ginsburg et al. Sep 1988 A
4774949 Fogarty Oct 1988 A
4896670 Crittenden Jan 1990 A
4900314 Quackenbush Feb 1990 A
4905667 Foerster et al. Mar 1990 A
4957508 Kaneko et al. Sep 1990 A
4983166 Yamawaki Jan 1991 A
4994071 Gregor Feb 1991 A
5054501 Chuttani et al. Oct 1991 A
5122125 Deuss Jun 1992 A
5147317 Shank et al. Sep 1992 A
5156620 Pigott Oct 1992 A
5217440 Frassica Jun 1993 A
5219355 Parodi et al. Jun 1993 A
5244619 Burnham Sep 1993 A
5320605 Sahota Jun 1994 A
5337733 Bauerfeind et al. Aug 1994 A
5342387 Summers Aug 1994 A
5350395 Yock Sep 1994 A
5387235 Chuter Feb 1995 A
5404887 Prather Apr 1995 A
5417208 Winkler May 1995 A
5443497 Venbrux Aug 1995 A
5445624 Jimenez Aug 1995 A
5456712 Maginot Oct 1995 A
5458605 Klemm Oct 1995 A
5476471 Shifrin et al. Dec 1995 A
5487730 Marcadis et al. Jan 1996 A
5489271 Andersen Feb 1996 A
5496292 Burnham Mar 1996 A
5575771 Walinsky Nov 1996 A
5578074 Mirigian Nov 1996 A
5591228 Edoga Jan 1997 A
5599300 Weaver et al. Feb 1997 A
5607444 Lam et al. Mar 1997 A
5609605 Marshall et al. Mar 1997 A
5609627 Goicoechea et al. Mar 1997 A
5613980 Chauhan Mar 1997 A
5617878 Taheri Apr 1997 A
5618299 Khosravi et al. Apr 1997 A
5632762 Myler May 1997 A
5632763 Glastra May 1997 A
5632772 Alcime et al. May 1997 A
5636641 Fariabi Jun 1997 A
5639278 Dereume et al. Jun 1997 A
5669905 Scheldrup Sep 1997 A
5669924 Shaknovich Sep 1997 A
5669932 Fischell et al. Sep 1997 A
5672153 Lax et al. Sep 1997 A
5676697 McDonald Oct 1997 A
5683450 Goicoechea et al. Nov 1997 A
5693086 Goicoechea et al. Dec 1997 A
5697971 Fischell et al. Dec 1997 A
5707348 Krogh Jan 1998 A
5709713 Evans et al. Jan 1998 A
5720735 Dorros Feb 1998 A
5735872 Carpenter et al. Apr 1998 A
5749825 Fischell et al. May 1998 A
5749890 Shaknovich May 1998 A
5755734 Richter et al. May 1998 A
5755735 Richter et al. May 1998 A
5755770 Ravenscroft May 1998 A
5755771 Penn et al. May 1998 A
5755772 Evans et al. May 1998 A
5755773 Evans et al. May 1998 A
5755778 Kleshinski May 1998 A
5776101 Goy Jul 1998 A
5782906 Marshall et al. Jul 1998 A
5797951 Mueller Aug 1998 A
5800508 Goicoechea et al. Sep 1998 A
5800520 Fogarty et al. Sep 1998 A
5824036 Lauterjung Oct 1998 A
5824040 Cox et al. Oct 1998 A
5827320 Richter et al. Oct 1998 A
5851464 Davila et al. Dec 1998 A
5855600 Alt Jan 1999 A
5868777 Lam Feb 1999 A
5893887 Jayaraman Apr 1999 A
5906640 Penn et al. May 1999 A
5916263 Goicoechea et al. Jun 1999 A
5921995 Kleshinski Jul 1999 A
5938696 Goicoechea et al. Aug 1999 A
5961490 Adams Oct 1999 A
5961548 Shmulewitz Oct 1999 A
5968089 Krajicek Oct 1999 A
5972017 Berg et al. Oct 1999 A
5984929 Bashiri Nov 1999 A
5984955 Wisselink Nov 1999 A
5993481 Marcade et al. Nov 1999 A
6013054 Jiun Yan Jan 2000 A
6013091 Ley et al. Jan 2000 A
6016810 Ravenscroft Jan 2000 A
6017324 Tu et al. Jan 2000 A
6017363 Hojeibane Jan 2000 A
6030414 Taheri Feb 2000 A
6033433 Her Mar 2000 A
6033434 Borghi Mar 2000 A
6033435 Penn et al. Mar 2000 A
6039758 Quiachon et al. Mar 2000 A
6045557 White et al. Apr 2000 A
6048360 Khosravi et al. Apr 2000 A
6048361 Von Gepen Apr 2000 A
6051020 Goicoechea et al. Apr 2000 A
6056722 Jayaraman May 2000 A
6056775 Borghi et al. May 2000 A
6059824 Taheri May 2000 A
6068655 Seguin et al. May 2000 A
6071298 Lashinski et al. Jun 2000 A
6086611 Duffy et al. Jul 2000 A
6090133 Richter et al. Jul 2000 A
6093203 Uflacker Jul 2000 A
6096073 Webster et al. Aug 2000 A
6099497 Adams et al. Aug 2000 A
6099558 White Aug 2000 A
6099560 Penn et al. Aug 2000 A
6102938 Evans et al. Aug 2000 A
6113579 Eidenschink Sep 2000 A
6117117 Mauch Sep 2000 A
6117156 Richter et al. Sep 2000 A
6129738 Lashinski et al. Oct 2000 A
6129754 Kanesaka Oct 2000 A
6132459 Piplani et al. Oct 2000 A
6142973 Carleton et al. Nov 2000 A
6143002 Vietmeier Nov 2000 A
6159238 Killion et al. Dec 2000 A
6165195 Wilson et al. Dec 2000 A
6165213 Goicoechea et al. Dec 2000 A
6168621 Vrba Jan 2001 B1
6183509 Dibie Feb 2001 B1
6197046 Piplani et al. Mar 2001 B1
6197049 Shaolian et al. Mar 2001 B1
6203568 Lombardi et al. Mar 2001 B1
6210380 Mauch Apr 2001 B1
6210429 Vardi Apr 2001 B1
6210431 Power Apr 2001 B1
6210433 Larre Apr 2001 B1
6217527 Selmon et al. Apr 2001 B1
6221080 Power Apr 2001 B1
6221090 Wilson Apr 2001 B1
6221098 Wilson et al. Apr 2001 B1
6231563 White et al. May 2001 B1
6231598 Berry et al. May 2001 B1
6238430 Klumb et al. May 2001 B1
6248122 Klumb et al. Jun 2001 B1
6251133 Richter et al. Jun 2001 B1
6254593 Wilson Jul 2001 B1
6258073 Mauch Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6258116 Hojeibane Jul 2001 B1
6261273 Ruiz Jul 2001 B1
6261305 Marotta et al. Jul 2001 B1
6261316 Shaolian et al. Jul 2001 B1
6264662 Lauterjung Jul 2001 B1
6264686 Rieu et al. Jul 2001 B1
6273909 Kugler et al. Aug 2001 B1
6287277 Yan Sep 2001 B1
6290673 Shanley Sep 2001 B1
6293968 Taheri Sep 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6302908 Parodi Oct 2001 B1
6306164 Kujawski Oct 2001 B1
6312461 Unsworth et al. Nov 2001 B1
6319278 Quinn et al. Nov 2001 B1
6322587 Quiachon et al. Nov 2001 B1
6325819 Pavcnik et al. Dec 2001 B1
6325822 Chouinard et al. Dec 2001 B1
6325826 Vardi Dec 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6334870 Ehr Jan 2002 B1
6346089 Dibie Feb 2002 B1
6355060 Lenker et al. Mar 2002 B1
6361544 Wilson et al. Mar 2002 B1
6361555 Wilson Mar 2002 B1
6383213 Wilson et al. May 2002 B2
6387120 Wilson et al. May 2002 B2
6395018 Castaneda May 2002 B1
6436104 Hojeibane Aug 2002 B2
6436134 Richter Aug 2002 B2
6468301 Amplatz et al. Oct 2002 B1
6508836 Wilson et al. Jan 2003 B2
6514228 Hamilton Feb 2003 B1
6517515 Eidenschink Feb 2003 B1
6517558 Gittings et al. Feb 2003 B2
6520988 Colombo et al. Feb 2003 B1
6537284 Priddy Mar 2003 B1
6540779 Richter et al. Apr 2003 B2
6579308 Jansen Jun 2003 B1
6579309 Loos Jun 2003 B1
6579312 Wilson et al. Jun 2003 B2
6582394 Reiss Jun 2003 B1
6596020 Vardi et al. Jul 2003 B2
6599315 Wilson Jul 2003 B2
6599316 Vardi Jul 2003 B2
6645242 Quinn Nov 2003 B1
6689156 Davidson et al. Feb 2004 B1
6692483 Vardi et al. Feb 2004 B2
6694877 Brucker Feb 2004 B1
6695877 Brucker et al. Feb 2004 B2
6706062 Vardi et al. Mar 2004 B2
6749628 Callol et al. Jun 2004 B1
6776793 Brown et al. Aug 2004 B2
6811566 Penn et al. Nov 2004 B1
6835203 Vardi Dec 2004 B1
6858038 Heuser Feb 2005 B2
6884258 Vardi et al. Apr 2005 B2
6896699 Wilson et al. May 2005 B2
6932837 Amplatz et al. Aug 2005 B2
6955687 Richter et al. Oct 2005 B2
6955688 Wilson et al. Oct 2005 B2
6962602 Vardi et al. Nov 2005 B2
7018400 Lashinski et al. Mar 2006 B2
7056323 Mareiro et al. Jun 2006 B2
7060091 Killion et al. Jun 2006 B2
20010002443 Parodi May 2001 A1
20010002927 Detampel Jun 2001 A1
20010002943 Nagayama et al. Jun 2001 A1
20010003161 Vardi et al. Jun 2001 A1
20010004705 Killion et al. Jun 2001 A1
20010004706 Hojeibane Jun 2001 A1
20010004707 Dereume et al. Jun 2001 A1
20010004823 Cronin et al. Jun 2001 A1
20010007954 Shaolian et al. Jul 2001 A1
20010012927 Mauch Aug 2001 A1
20010016766 Vardi et al. Aug 2001 A1
20010016767 Wilson et al. Aug 2001 A1
20010016768 Wilson et al. Aug 2001 A1
20010020173 Klumb et al. Sep 2001 A1
20010020184 Dehdashtian et al. Sep 2001 A1
20010025195 Shaolian et al. Sep 2001 A1
20010027291 Shanley Oct 2001 A1
20010027338 Greenberg Oct 2001 A1
20010029396 Wilson et al. Oct 2001 A1
20010037116 Wilson et al. Nov 2001 A1
20010037138 Wilson et al. Nov 2001 A1
20010039448 Dibie Nov 2001 A1
20010049552 Richter et al. Dec 2001 A1
20010056297 Hojeibane Dec 2001 A1
20020013618 Marotta et al. Jan 2002 A1
20020013619 Shanley Jan 2002 A1
20020022874 Wilson Feb 2002 A1
20020026232 Marotta et al. Feb 2002 A1
20020035392 Wilson Mar 2002 A1
20020042650 Vardi et al. Apr 2002 A1
20020052648 McGuckin, Jr. et al. May 2002 A1
20020072790 McGuckin, Jr. et al. Jun 2002 A1
20020111675 Wilson Aug 2002 A1
20020156516 Vardi et al. Oct 2002 A1
20020156517 Perouse Oct 2002 A1
20020165604 Shanley Nov 2002 A1
20020173835 Bourang et al. Nov 2002 A1
20020173840 Brucker et al. Nov 2002 A1
20020183763 Callol et al. Dec 2002 A1
20020193872 Trout, III et al. Dec 2002 A1
20020193873 Brucker Dec 2002 A1
20030009209 Hojeibane Jan 2003 A1
20030028233 Vardi et al. Feb 2003 A1
20030050688 Fischell et al. Mar 2003 A1
20030055378 Wang et al. Mar 2003 A1
20030055483 Gumm Mar 2003 A1
20030074047 Richter Apr 2003 A1
20030093109 Mauch May 2003 A1
20030097169 Brucker et al. May 2003 A1
20030114912 Sequin et al. Jun 2003 A1
20030125791 Sequin et al. Jul 2003 A1
20030125802 Callol et al. Jul 2003 A1
20030135259 Simso Jul 2003 A1
20030181923 Vardi Sep 2003 A1
20030195606 Davidson Oct 2003 A1
20040006381 Sequin et al. Jan 2004 A1
20040015227 Vardi et al. Jan 2004 A1
20040044396 Clerc et al. Mar 2004 A1
20040059406 Cully et al. Mar 2004 A1
20040088007 Eidenschink May 2004 A1
20040117003 Ouriel et al. Jun 2004 A1
20040133268 Davidson et al. Jul 2004 A1
20040138732 Suhr et al. Jul 2004 A1
20040138737 Davidson Jul 2004 A1
20040148006 Davidson et al. Jul 2004 A1
20040172121 Eidenschink et al. Sep 2004 A1
20040186560 Alt Sep 2004 A1
20040225345 Fischell et al. Nov 2004 A1
20040267352 Davidson et al. Dec 2004 A1
20050004656 Das Jan 2005 A1
20050010278 Vardi Jan 2005 A1
20050015108 Williams et al. Jan 2005 A1
20050015135 Shanley Jan 2005 A1
20050060027 Khenansho et al. Mar 2005 A1
20050096726 Sequin et al. May 2005 A1
20050102021 Osborne May 2005 A1
20050102023 Yadin May 2005 A1
20050119731 Brucker et al. Jun 2005 A1
20050125076 Ginn Jun 2005 A1
20050131526 Wong Jun 2005 A1
20050149161 Eidenschink et al. Jul 2005 A1
20050154442 Eidenschink et al. Jul 2005 A1
20050154444 Quadri Jul 2005 A1
20050183259 Eidenschink et al. Aug 2005 A1
20050209673 Shaked Sep 2005 A1
20050228483 Kaplan Oct 2005 A1
20060036315 Yadin et al. Feb 2006 A1
20060041303 Israel Feb 2006 A1
20060079956 Eigler et al. Apr 2006 A1
20060173528 Feld et al. Aug 2006 A1
20070073376 Krolik et al. Mar 2007 A1
Foreign Referenced Citations (122)
Number Date Country
2220864 Jul 1999 CA
9014845 Feb 1991 DE
29701758 Mar 1997 DE
29708803 Jul 1997 DE
0347023 Dec 1989 EP
0479730 Apr 1992 EP
0647148 Apr 1995 EP
0686379 Dec 1995 EP
0804907 Nov 1997 EP
0751752 Jun 1998 EP
0479557 Jul 1998 EP
0876805 Nov 1998 EP
0880949 Dec 1998 EP
0891751 Jan 1999 EP
0895759 Feb 1999 EP
0904745 Mar 1999 EP
0937442 Aug 1999 EP
0783873 Apr 2000 EP
1031328 Aug 2000 EP
1031329 Aug 2000 EP
0883384 Dec 2000 EP
0862392 Aug 2001 EP
0808140 Dec 2001 EP
0884028 Feb 2002 EP
1190685 Mar 2002 EP
0897700 Jul 2002 EP
0684022 Feb 2004 EP
1157674 Jul 2005 EP
1031330 Nov 2005 EP
1070513 Jun 2006 EP
2678508 Jan 1993 FR
2740346 Apr 1997 FR
2756173 May 1998 FR
2760351 Sep 1998 FR
2337002 Nov 1999 GB
8806026 Aug 1988 WO
9219308 Nov 1992 WO
9521592 Aug 1995 WO
9629955 Oct 1996 WO
9634580 Nov 1996 WO
9641592 Dec 1996 WO
9707752 Mar 1997 WO
9715346 May 1997 WO
9716217 May 1997 WO
9726936 Jul 1997 WO
9741803 Nov 1997 WO
9745073 Dec 1997 WO
9746174 Dec 1997 WO
9819628 May 1998 WO
9831306 Jul 1998 WO
9836709 Aug 1998 WO
9837833 Sep 1998 WO
9847446 Oct 1998 WO
9847447 Oct 1998 WO
9848879 Nov 1998 WO
9853759 Dec 1998 WO
9903426 Jan 1999 WO
9904726 Feb 1999 WO
9913808 Mar 1999 WO
9915103 Apr 1999 WO
9915108 Apr 1999 WO
9915109 Apr 1999 WO
9924104 May 1999 WO
9934749 Jul 1999 WO
9936002 Jul 1999 WO
9936015 Jul 1999 WO
9944539 Sep 1999 WO
9956661 Nov 1999 WO
9965419 Dec 1999 WO
0007523 Feb 2000 WO
0010485 Mar 2000 WO
0010489 Mar 2000 WO
0013613 Mar 2000 WO
0016719 Mar 2000 WO
0027307 May 2000 WO
0027463 May 2000 WO
0028922 May 2000 WO
0032266 Jun 2000 WO
0145594 Jun 2000 WO
0044307 Aug 2000 WO
0044309 Aug 2000 WO
0047134 Aug 2000 WO
0048531 Aug 2000 WO
0049951 Aug 2000 WO
0051523 Sep 2000 WO
0057813 Oct 2000 WO
0071054 Nov 2000 WO
0067673 Nov 2000 WO
0071055 Nov 2000 WO
0074595 Dec 2000 WO
0121095 Mar 2001 WO
0121109 Mar 2001 WO
01021244 Mar 2001 WO
0130433 May 2001 WO
0135715 May 2001 WO
0135863 May 2001 WO
0139697 Jun 2001 WO
0139699 Jun 2001 WO
0141677 Jun 2001 WO
0143665 Jun 2001 WO
0143809 Jun 2001 WO
0145785 Jun 2001 WO
0149342 Jul 2001 WO
0154621 Aug 2001 WO
0154622 Aug 2001 WO
0158385 Aug 2001 WO
0160284 Aug 2001 WO
0170294 Sep 2001 WO
0170299 Sep 2001 WO
0174273 Oct 2001 WO
0189409 Nov 2001 WO
0200138 Jan 2002 WO
02053066 Jul 2002 WO
02068012 Sep 2002 WO
03007842 Jan 2003 WO
03055414 Jul 2003 WO
03063924 Aug 2003 WO
2004026174 Apr 2004 WO
2004026180 Apr 2004 WO
2005009295 Feb 2005 WO
2005014077 Feb 2005 WO
2006028925 Mar 2006 WO
Non-Patent Literature Citations (13)
Entry
Chevalier, M.D., Bernard, “Placement of Coronary Stents in Bifurcation Lesions by the “Culotte” Technique,” The American Journal of Cardiology, vol. 82, pp. 943-949 (Oct. 15, 1998).
Nakamura M.D., Shigeru, “Techniques for Palmaz-Schatz Stent Deployment in Lesions with a Large Side Branch,” Catheterization and Cardiovascular Diagnosis, vol. 34, pp. 353-361 (1995).
Caputo, Ronald P., “Stent Jail: A Minimum-Security Prison,” The American Journal of Cardiology, vol. 77, pp. 1226-1230 (Jun. 1, 1996).
Colombo, M.D., Antonio, ““Kissing” Stent for Bifurcational Coronary Lesion,” Catheterization and Cardiovascular Diagnosis, vol. 30, pp. 327-330 (Dec. 1993).
Carrie, M.D., Didier, ““T”-Shaped Stent Placement: A Technique for the Treatment of Dissected Bifurcation Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 37, pp. 311-313 (Mar. 1996).
Katoh, M.D., Osamu, “New Double Wire Technique to Stent Ostial Lesions,” Catheterization and Cardiovascular Diagnosis, vol. 40, pp. 400-402 (Apr. 1997).
Lewis, M.D., Bruce E., “Acute procedural results in the treatment of 30 coronary artery bifurcation lesions with a double-wire atherectomy technique for side-branch protection,” American Heart Journal, vol. 127:6, pp. 1600-1607 (Jun. 1994).
Yamashita, M.D.,PhD., Takehiro, “Bifurcation Lesions: Two Stents Versus One Stent—Immediate and Follow-up Results,” Journal of the American College of Cardiology, vol. 35:5, pp. 1145-1151 (Apr. 2000).
Satler, M.D., Lowell F., “Bifurcation Disease: To Treat or Not to Treat,” Catheterization and Cardiovascular Interventions, vol. 50, pp. 411-412 (2000).
U.S. Appl. No. 9/325,996, filed Jun. 4, 1999, Vardi et al.
U.S. Appl. No. 9/614,472, filed Jul. 11, 2000, Davidson et al.
U.S. Appl. No. 9/663,111, filed Sep. 15, 2000, Davidson et al.
TRIO™ 14 PTCA Catheter, Re-engineering Over the Wire Balloon Technology, Company Brochure Copyright 1994.
Related Publications (1)
Number Date Country
20070135904 A1 Jun 2007 US